Share This Link

Substitute the scheduled vaccine with an alternative vaccine that has no association with GBS.: Simply substituting another vaccine is not appropriate because not all vaccines have equivalent indications, and an alternative may not provide the necessary protection against the intended disease. Additionally, the decision to administer an alternative vaccine should only be made after a thorough clinical assessment by the healthcare provider. The nurse should not independently substitute prescribed immunizations.

Proceed with the immunization and prepare to manage potential GBS manifestations if they recur.: Administering the vaccine without first evaluating the client's history is inappropriate and may expose the client to unnecessary risk. Although recurrence of GBS after vaccination is uncommon, the possibility should be carefully considered before immunization. Preventing a potential adverse event through appropriate assessment is preferable to treating complications after they occur.

Administer the vaccine as scheduled since GBS is not a contraindication for immunization.: This statement is inaccurate because a history of GBS following a previous immunization is considered a precaution for certain vaccines, particularly when the syndrome developed within 6 weeks of vaccination. The client's history should prompt additional evaluation rather than automatic administration of the vaccine. Ignoring this precaution could compromise patient safety and is inconsistent with current immunization recommendations.

Hypomagnesemia: Although hypomagnesemia may occur in clients receiving certain diuretics or experiencing gastrointestinal losses, it is not the electrolyte imbalance most commonly associated with high-dose corticosteroid therapy. Corticosteroids primarily affect sodium and potassium balance through their mineralocorticoid effects. Therefore, magnesium depletion is not the expected electrolyte abnormality in this clinical scenario.

Hypermagnesemia: Hypermagnesemia most commonly develops in clients with severe renal failure who are unable to excrete magnesium or in those receiving excessive magnesium-containing medications. Corticosteroids do not promote magnesium retention and are not typically associated with elevated serum magnesium levels. Therefore, this is not the electrolyte imbalance the nurse should primarily anticipate.

Hyperkalemia: Hyperkalemia is generally associated with conditions that impair potassium excretion, such as advanced kidney failure, hypoaldosteronism, or the use of potassium-sparing medications. Corticosteroids have the opposite effect by enhancing urinary potassium loss rather than promoting potassium retention. Consequently, hyperkalemia is not the expected electrolyte imbalance in clients receiving high-dose corticosteroid therapy.

"I can expect to have swelling in my face.": Facial edema, particularly around the eyes, is a common manifestation of nephrotic syndrome due to hypoalbuminemia and decreased plasma oncotic pressure. As fluid shifts from the intravascular space into the tissues, edema often develops in the face, especially upon awakening, before progressing to dependent areas. This statement demonstrates an appropriate understanding of the condition.

"I will lose protein in my urine.": Heavy proteinuria is the hallmark feature of nephrotic syndrome and results from increased permeability of the glomerular filtration membrane. Significant amounts of albumin are lost in the urine, contributing to hypoalbuminemia and generalized edema. This statement accurately reflects the underlying pathophysiology of the disorder.

"I should expect my provider to prescribe a kidney biopsy.": A kidney biopsy is commonly performed to determine the underlying cause of nephrotic syndrome, particularly in adults or when the diagnosis is uncertain. Histopathologic examination helps identify the specific glomerular disease and guides treatment decisions. This statement indicates an appropriate understanding of a frequently used diagnostic procedure.

Serum sodium 146 mEq/L: A serum sodium level of 146 mEq/L is slightly above the normal reference range of approximately 135–145 mEq/L and may indicate persistent free water loss. Clients with untreated diabetes insipidus commonly develop hypernatremia because excessive water is lost without adequate replacement. Although this value is only mildly elevated, it does not provide the best evidence that desmopressin therapy is effectively concentrating urine.

Blood glucose 80 mg/dL: A blood glucose level of 80 mg/dL is within the normal range but is unrelated to the therapeutic action of desmopressin. Diabetes insipidus affects water balance rather than glucose metabolism and should not be confused with diabetes mellitus. Therefore, blood glucose is not an appropriate indicator of the medication's effectiveness.

Blood urea nitrogen (BUN) 15 mg/dL: A BUN level of 15 mg/dL falls within the normal reference range and reflects normal renal function and hydration status. However, BUN is not the most sensitive or direct indicator of desmopressin effectiveness in diabetes insipidus. Changes in urine concentration and urine specific gravity provide a more accurate assessment of the medication's therapeutic action.

"Are you taking a multivitamin?": Although obtaining a medication history is part of a comprehensive assessment, multivitamin use has no established association with the development of Guillain-Barré syndrome. This question is unlikely to provide information that supports or rules out the diagnosis. Therefore, it is not a priority assessment question when GBS is suspected.

"Do have a history of chronic alcohol abuse?": Chronic alcohol abuse can contribute to peripheral neuropathy due to nutritional deficiencies and direct neurotoxicity, but it is not a common precipitating factor for Guillain-Barré syndrome. Alcohol-related neuropathy typically develops gradually rather than presenting with the acute, ascending paralysis characteristic of GBS. Consequently, this question is less relevant to the suspected diagnosis.

"Have traveled overseas recently?": Recent travel may be important when assessing exposure to certain infectious diseases, but it is not a primary risk factor associated with Guillain-Barré syndrome. While some travel-related infections can trigger GBS, travel history alone is less significant than determining whether the client experienced a recent respiratory or gastrointestinal infection. Therefore, this is not the highest-priority assessment question.

Hypertension: Blood pressure in children with nephrotic syndrome is often normal or only mildly elevated because the primary abnormality is protein loss rather than reduced glomerular filtration. Significant hypertension is more commonly associated with nephritic syndrome due to sodium retention and decreased renal function. Therefore, hypertension is not the expected hallmark finding in nephrotic syndrome.

Smokey brown urine: Smokey brown or tea-colored urine indicates the presence of blood in the urine and is characteristic of nephritic syndrome, particularly acute poststreptococcal glomerulonephritis. Nephrotic syndrome is primarily associated with massive proteinuria rather than hematuria. Although microscopic hematuria may occasionally occur, dark or smoky urine is not an expected manifestation.

Polyuria: Children with nephrotic syndrome are more likely to experience decreased urine output (oliguria) during periods of significant edema because fluid shifts into the interstitial space reduce effective circulating blood volume. The urine is often concentrated and contains large amounts of protein rather than being excessive in volume. Therefore, polyuria is not an expected finding in nephrotic syndrome.

Confusion: Myasthenia gravis primarily affects the neuromuscular junction and does not impair cognitive function or alter the client's level of consciousness. Clients typically remain alert and oriented despite experiencing significant muscle weakness. If confusion develops, the nurse should investigate other causes such as hypoxia, infection, medication effects, or metabolic disturbances rather than attributing it to myasthenia gravis.

Increased intracranial pressure: Increased intracranial pressure is associated with conditions such as traumatic brain injury, intracranial hemorrhage, brain tumors, or cerebral edema. Myasthenia gravis does not affect intracranial structures or cerebrospinal fluid dynamics. Therefore, manifestations such as headache, vomiting, altered consciousness, or papilledema are not expected findings of this disorder.

Increased urinary output: Myasthenia gravis affects voluntary skeletal muscles and does not directly alter renal function or urine production. Increased urinary output is more commonly associated with conditions such as diabetes mellitus, diabetes insipidus, excessive fluid intake, or diuretic therapy. Therefore, polyuria is not an expected manifestation of myasthenia gravis and does not reflect disease progression.

Dry mucous membranes: Dry mucous membranes may occur as conivaptan promotes free water excretion and can indicate mild dehydration if fluid loss exceeds replacement. Although this finding warrants assessment of the client's hydration status and fluid balance, it is not usually an emergency. The nurse should continue monitoring intake, output, vital signs, and laboratory values while encouraging fluid management as prescribed.

Urine specific gravity 1.020: A urine specific gravity of 1.020 is within the normal reference range and does not independently indicate an urgent problem. Although clients with untreated SIADH often have concentrated urine, urine concentration may gradually change as treatment becomes effective. This value should be interpreted alongside the client's overall fluid status and serum sodium level but does not require immediate provider notification.

Serum sodium 130 mEq/L: A serum sodium level of 130 mEq/L indicates mild hyponatremia, which is commonly present in clients with SIADH. Although sodium levels should be monitored closely to evaluate treatment response, this value alone is not an immediate emergency in a stable client receiving therapy. More concerning findings would include severe hyponatremia accompanied by neurological manifestations such as seizures, confusion, or decreased level of consciousness.